Welcome to our book review site go-pdf.online!

You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.

Sign up

Neuropsychiatric Disorders
  • Language: en
  • Pages: 326

Neuropsychiatric Disorders

This multidisciplinary book includes current research papers and reviews in the areas of basic neuroscience, neural mechanisms underlying neurodegenerative disorders. It further includes new approaches for neuroprotective treatments, clinical, neurobiological and treatment aspects of psychiatric disorders. The book was conceived as a celebration of the professional life and work of Peter Riederer to mark the occasion of his retirement.

Movement Disorders
  • Language: en
  • Pages: 406

Movement Disorders

The human nervous system-that most complex organization of energy and matter-has yielded a few glimmers of understanding of its operational me chanics during the last two decades. These have mostly been at the biochemical level of structure and function. Throughout history, as one of the mysteries of nature begins to yield some insights into its function, it has been beneficial to look at it from different points of view. We have developed a volume on movement disorders that is primarily directed toward the biochemical understanding of these disorders and their treatment. Each disorder is presented from several points of view. Although this approach leads to some repetition, it is our aim th...

How Selegiline ((-)-Deprenyl) Slows Brain Aging
  • Language: en
  • Pages: 161

How Selegiline ((-)-Deprenyl) Slows Brain Aging

This e-book is a reference on Selegiline ((-)-Deprenyl) effects on the brain. Selegiline, described in thousands of research papers, is registered in over 60 countries. At present, more than one hundred preparations containing selegiline circulate in the global market under different brand names. They are widely used in the treatment of Parkinson's disease, Alzheimer's disease, major depression and as a geroprotective / anti-aging drug. ((-)-Deprenyl) selegiline, the first selective inhibitor of B-type MAO which, in contrast to the known MAO inhibitors, did not potentiate the effect of tyramine but inhibited it. the compound could be combined with levodopa in Parkinson's disease without sign...

Jet
  • Language: en
  • Pages: 64

Jet

  • Type: Magazine
  • -
  • Published: 1983-08-22
  • -
  • Publisher: Unknown

The weekly source of African American political and entertainment news.

The German Colonial Empire
  • Language: en
  • Pages: 289

The German Colonial Empire

Although Germany's short-lived colonial empire (1884-1918) was neither large nor successful, it is historically significant. The establishment of German colonies and attempts to expand them affected international politics in a period of extreme tension. Smith focuses on the interaction between Germany's colonial empire and German politics and, by extension, on the connection between colonialism and socioeconomic conflict in Germany before World War I. Originally published in 1978. A UNC Press Enduring Edition -- UNC Press Enduring Editions use the latest in digital technology to make available again books from our distinguished backlist that were previously out of print. These editions are published unaltered from the original, and are presented in affordable paperback formats, bringing readers both historical and cultural value.

The Parsonage in India
  • Language: en
  • Pages: 308

The Parsonage in India

  • Type: Book
  • -
  • Published: 1881
  • -
  • Publisher: Unknown

None

Report of the Adjutant General
  • Language: en
  • Pages: 708

Report of the Adjutant General

  • Type: Book
  • -
  • Published: 1867
  • -
  • Publisher: Unknown

None

Abstracts
  • Language: en
  • Pages: 696

Abstracts

  • Type: Book
  • -
  • Published: 2013-09-11
  • -
  • Publisher: Elsevier

Abstracts of the Sixth International Congress of Pharmacology deals with papers submitted during the pharmacology congress held at Helsinki in 1975. This collection of papers deals with research and development in pharmacology and biotherapeutic drugs. The wide array of subjects deals with the therapeutic implications of controlled drug delivery and the methods of drug application, including pharmacological investigations on cell in a culture. The book also contains papers about the interactions of neurotransmitters and the hypothalamic releasing hormones and toxins as tools in receptor studies. Some papers also deal with behavioral pharmacology that covers drug dependence, narcotic analgesi...

Hell Before Their Very Eyes
  • Language: en
  • Pages: 208

Hell Before Their Very Eyes

The life-altering experiences of the American soldiers who liberated three Nazi concentration camps. On April 4, 1945, United States Army units from the 89th Infantry Division and the 4th Armored Division seized Ohrdruf, the first of many Nazi concentration camps to be liberated in Germany. In the weeks that followed, as more camps were discovered, thousands of soldiers came face to face with the monstrous reality of Hitler’s Germany. These men discovered the very depths of human-imposed cruelty and depravity: railroad cars stacked with emaciated, lifeless bodies; ovens full of incinerated human remains; warehouses filled with stolen shoes, clothes, luggage, and even eyeglasses; prison yar...

Towards New Therapies for Parkinson's Disease
  • Language: en
  • Pages: 412

Towards New Therapies for Parkinson's Disease

Parkinson's disease (PD) is characterised clinically by various non-motor and progressive motor symptoms, pathologically by loss of dopamine producing cells and intraneuronal cytoplasmic inclusions composed primarily of ?-synuclein. By the time a patient first presents with symptoms of Parkinson's disease at the clinic, a significant proportion of the cells in the substantia nigra have already been destroyed. This degeneration progresses despite the current therapies until the cell loss is so great that the quality of normal life is compromised. The dopamine precursor levodopa is the most valuable drug currently available for the treatment of PD. However for most PD patients, the optimal clinical benefit from levodopa decreases around five to six years of treatment. The aim of the chapters of this book is to work towards an understanding in the mechanisms of degeneration and to develop disease modifying therapies.